Innoviva, Inc. (INVA)
21.03
-0.04
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
21.03
0.00 (0.00%)
After-Hours: 20:00
Innoviva Total Assets (Quarterly) : 1.703B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.703B |
| March 31, 2026 | 1.837B |
| December 31, 2025 | 1.635B |
| September 30, 2025 | 1.429B |
| June 30, 2025 | 1.334B |
| March 31, 2025 | 1.254B |
| December 31, 2024 | 1.335B |
| September 30, 2024 | 1.232B |
| June 30, 2024 | 1.225B |
| March 31, 2024 | 1.268B |
| December 31, 2023 | 1.244B |
| September 30, 2023 | 1.188B |
| June 30, 2023 | 1.118B |
| March 31, 2023 | 1.130B |
| December 31, 2022 | 1.231B |
| September 30, 2022 | 1.328B |
| June 30, 2022 | 1.138B |
| March 31, 2022 | 1.107B |
| December 31, 2021 | 926.40M |
| September 30, 2021 | 887.24M |
| June 30, 2021 | 789.15M |
| March 31, 2021 | 1.088B |
| December 31, 2020 | 999.57M |
| September 30, 2020 | 922.26M |
| June 30, 2020 | 879.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 788.01M |
| December 31, 2019 | 724.83M |
| September 30, 2019 | 675.95M |
| June 30, 2019 | 642.31M |
| March 31, 2019 | 590.11M |
| December 31, 2018 | 548.19M |
| September 30, 2018 | 277.69M |
| June 30, 2018 | 338.69M |
| March 31, 2018 | 276.74M |
| December 31, 2017 | 367.34M |
| September 30, 2017 | 390.97M |
| June 30, 2017 | 372.02M |
| March 31, 2017 | 391.87M |
| December 31, 2016 | 379.00M |
| September 30, 2016 | 370.54M |
| June 30, 2016 | 378.11M |
| March 31, 2016 | 387.83M |
| December 31, 2015 | 424.07M |
| September 30, 2015 | 437.63M |
| June 30, 2015 | 462.09M |
| March 31, 2015 | 488.70M |
| December 31, 2014 | 521.65M |
| September 30, 2014 | 553.71M |
| June 30, 2014 | 605.61M |
| March 31, 2014 | 605.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 302.71M |
| Collegium Pharmaceutical, Inc. | 2.136B |
| CorMedix, Inc. | 904.05M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 469.46M |
| Shareholders Equity (Quarterly) | 1.233B |
| Debt to Equity Ratio | 0.2187 |
| Current Ratio | 16.01 |
| Net Debt Paydown Yield | 2.20% |